Skip to main content
Top
Published in: Medical Oncology 4/2011

01-12-2011 | Original Paper

A clinicopathological study of resected non-small cell lung cancers 2 cm or less in diameter: a prognostic assessment

Authors: Chun-Lei Shi, Xue-Yan Zhang, Bao-Hui Han, Wei-Zhong He, Jie Shen, Tian-Qing Chu

Published in: Medical Oncology | Issue 4/2011

Login to get access

Abstract

The detection and diagnosis of small-sized (2 cm or less) non-small cell lung cancer (NSCLC) has increased with the development of computed tomography (CT). Over 80% of 5-year survival rate has been reported in surgically treated peripheral lung cancer. There are systematic mediastinal and hilar lymph node involvement pleural invasion and intrapulmonary metastasis even with tumor diameter less than 2 cm. The appropriate surgical procedure for such kinds of lung cancer is lobectomy with mediastinal lymph node dissection. To evaluate the prognostic factors and establish the optimal surgical strategy, we analyzed the clinicopathologic features and survival benefit in different tumor size of peripheral small-sized NSCLC. Among the resected lung cancer cases between January 1999 and July 2001, 185 patients were retrospectively analyzed in surgical methods, lymph node involvement, CT scan findings and survival rates. Survival was analyzed by Kaplan–Meier method and log-rank test. Lymph node involvement was recognized in 26(14.05%) patients. There was no statistically significant difference in the incidence of lymph node involvement between tumors 1.6–2.0 cm (17.82%) in diameter than in those 1.0–1.5 cm (11.94%). There was no lymph node metastasis in tumors less than 1.0 cm in diameter. The 5-year survival rates with or without lymph node involvement were 89.98 and 46.15%, respectively, showing significant difference (P = 0.000). The overall 5-year survival rate was 83.78%. The 5-year survival rate in tumors 1.6–2.0 cm, 1.0–1.5 cm and less than 1.0 cm in diameter was 80.20, 85.07 and 100%, respectively, and showing significant difference(P = 0.035). The 5-year survival rate of 19 patients showing ground-glass opacity (GGO) on CT scan was 94.74% without any metastasis and recurrence after operation. There are systematic mediastinal and hilar lymph node involvement even with tumor diameter less than 2 cm. The results of the present study suggested that systematic lymph node dissection is necessary even for cases with tumor diameter less than 2 cm. However, if the tumor is within 1.0 cm in diameter with obvious GGO showing on chest CT scan, these are good candidates for partial resection without mediastinal lymph node dissection.
Literature
2.
go back to reference Arifa P, Pieter EP, Thomas GS. What is early lung cancer? A review of the literature. Lung cancer. 2004;45:267–77.CrossRef Arifa P, Pieter EP, Thomas GS. What is early lung cancer? A review of the literature. Lung cancer. 2004;45:267–77.CrossRef
3.
go back to reference Ginsberg RJ (2002) Role of surgery in the treatment of stage I and II lung cancer. American Society of Clinical Oncology 2002. Educational book. Thirty-Eight Annual Meeting. May 18–21, 2002, Orlando FL, 460–464. Ginsberg RJ (2002) Role of surgery in the treatment of stage I and II lung cancer. American Society of Clinical Oncology 2002. Educational book. Thirty-Eight Annual Meeting. May 18–21, 2002, Orlando FL, 460–464.
4.
go back to reference Park BJ, Altorki NK. Diagnosis and management of early lung cancer. Surg Clin North Am. 2002;82(3):457–76.PubMedCrossRef Park BJ, Altorki NK. Diagnosis and management of early lung cancer. Surg Clin North Am. 2002;82(3):457–76.PubMedCrossRef
5.
6.
go back to reference Henschke CI, Yankelevitz DF. CT screening for lung cancer: update 2007. Oncologist. 2008;13:65–78.PubMedCrossRef Henschke CI, Yankelevitz DF. CT screening for lung cancer: update 2007. Oncologist. 2008;13:65–78.PubMedCrossRef
7.
go back to reference Cassidy A, Duffy SW, Myles JP, et al. Lung cancer risk prediction: a tool for early detection. Int J Cancer. 2007;120:1–6.PubMedCrossRef Cassidy A, Duffy SW, Myles JP, et al. Lung cancer risk prediction: a tool for early detection. Int J Cancer. 2007;120:1–6.PubMedCrossRef
8.
go back to reference Watanabe T, Okada A, Imakiire T. Intentional limited resection for small peripheral lung cancer based on intraoperative pathologic exploration. Jpn J Thorac Cardiovasc Surg. 2005;53:29–35.PubMedCrossRef Watanabe T, Okada A, Imakiire T. Intentional limited resection for small peripheral lung cancer based on intraoperative pathologic exploration. Jpn J Thorac Cardiovasc Surg. 2005;53:29–35.PubMedCrossRef
9.
go back to reference Konaka C, Ikeda N, Hiyoshi T, et al. Peripheral non-small cell lung cancers 2.0 cm or less in diameter: proposed criteria for limited pulmonary resection based upon clinicopathological presentation. Lung Cancer. 1998;21:185–91.PubMedCrossRef Konaka C, Ikeda N, Hiyoshi T, et al. Peripheral non-small cell lung cancers 2.0 cm or less in diameter: proposed criteria for limited pulmonary resection based upon clinicopathological presentation. Lung Cancer. 1998;21:185–91.PubMedCrossRef
10.
go back to reference Watanabe S, Oda M, Go T, et al. Should mediastinal nodal dissection be routinely undertaken in patients with peripheral small-sized (2 cm or less) lung cancer? Retrospective analysis of 225 patients. Eur J Cardiothorac Surg. 2001;20:1007–11.PubMedCrossRef Watanabe S, Oda M, Go T, et al. Should mediastinal nodal dissection be routinely undertaken in patients with peripheral small-sized (2 cm or less) lung cancer? Retrospective analysis of 225 patients. Eur J Cardiothorac Surg. 2001;20:1007–11.PubMedCrossRef
11.
go back to reference Swanson SJ, Batirel HF. Video-assisted thoracic surgery (VATS) resection for lung cancer. Surg Clin North Am. 2002;82(3):541–59.PubMedCrossRef Swanson SJ, Batirel HF. Video-assisted thoracic surgery (VATS) resection for lung cancer. Surg Clin North Am. 2002;82(3):541–59.PubMedCrossRef
12.
go back to reference Shennib H, Bogart J, Herndon JE, Kohman L, Keenan R, Green M, et al. Video-assisted wedge resection and local radiotherapy for peripheral lung cancer in high-risk patients: the cancer and leukemia group B (CALGB) 9335, a phase II, multi-institutional cooperative group study. J Thorac Cardiovasc Surg. 2005;129:813–8.PubMedCrossRef Shennib H, Bogart J, Herndon JE, Kohman L, Keenan R, Green M, et al. Video-assisted wedge resection and local radiotherapy for peripheral lung cancer in high-risk patients: the cancer and leukemia group B (CALGB) 9335, a phase II, multi-institutional cooperative group study. J Thorac Cardiovasc Surg. 2005;129:813–8.PubMedCrossRef
13.
go back to reference Rusch VW. High-resolution computed tomography in clinical T1 N0 M0 adenocarcinoma of the lung[J]. J Thorac Cardiovasc Surg. 2002;124:221–2.PubMedCrossRef Rusch VW. High-resolution computed tomography in clinical T1 N0 M0 adenocarcinoma of the lung[J]. J Thorac Cardiovasc Surg. 2002;124:221–2.PubMedCrossRef
14.
go back to reference Ohtsuka T, Watanabe K, Kaji M, et al. A clinicopathological study of resected pulmonary nodules with focal pure ground-glass opacity. Eur J Cardiothorac Surg. 2006;30:160–3.PubMedCrossRef Ohtsuka T, Watanabe K, Kaji M, et al. A clinicopathological study of resected pulmonary nodules with focal pure ground-glass opacity. Eur J Cardiothorac Surg. 2006;30:160–3.PubMedCrossRef
16.
go back to reference Sobue T, Moriyama N, Kaneko M, et al. Screening for lung cancer with low-dose helical computed tomography: anti-lung cancer association project. J Clin Oncol. 2002;20:911–20.PubMedCrossRef Sobue T, Moriyama N, Kaneko M, et al. Screening for lung cancer with low-dose helical computed tomography: anti-lung cancer association project. J Clin Oncol. 2002;20:911–20.PubMedCrossRef
17.
go back to reference Koike T, Yamato Y, Yoshiya K, et al. Criteria for intentional limited pulmonary resection in cT1N0M0 peripheral lung cancer. Jpn J Thorac Cardiovasc Surg. 2003;51:515–9.PubMedCrossRef Koike T, Yamato Y, Yoshiya K, et al. Criteria for intentional limited pulmonary resection in cT1N0M0 peripheral lung cancer. Jpn J Thorac Cardiovasc Surg. 2003;51:515–9.PubMedCrossRef
18.
go back to reference Nakamura H, Saji H, Ogata A, et al. Lung cancer patients showing pure ground-glass opacity on computed tomography are good candidates for wedge resection. Lung Cancer. 2004;44:61–8.PubMedCrossRef Nakamura H, Saji H, Ogata A, et al. Lung cancer patients showing pure ground-glass opacity on computed tomography are good candidates for wedge resection. Lung Cancer. 2004;44:61–8.PubMedCrossRef
19.
go back to reference Matsuguma H, Yokoi K, Anraku M, et al. Proportion of ground-glass opacity on high-resolution computed tomography in clinical T1 N0 M0 adenocarcinoma of the lung a predictor of lymph node metastasis. J Thorac Cardiovasc Surg. 2002;124:278–84.PubMedCrossRef Matsuguma H, Yokoi K, Anraku M, et al. Proportion of ground-glass opacity on high-resolution computed tomography in clinical T1 N0 M0 adenocarcinoma of the lung a predictor of lymph node metastasis. J Thorac Cardiovasc Surg. 2002;124:278–84.PubMedCrossRef
20.
go back to reference Nakata M, Sawada S, Saeki H, et al. Prospective study of thoracoscopic limited resection for ground-glass opacity selected by computed tomography. Ann Thorac Surg. 2003;75:1601–5.PubMedCrossRef Nakata M, Sawada S, Saeki H, et al. Prospective study of thoracoscopic limited resection for ground-glass opacity selected by computed tomography. Ann Thorac Surg. 2003;75:1601–5.PubMedCrossRef
21.
go back to reference Ginsberg RJ, Rubinstein LV, Lung Study Group. Randomized trial of lobectomy versus limited resection for T1N0 non-small cell lung cancer. Ann Thorac Surg. 1995;60:615–23.PubMedCrossRef Ginsberg RJ, Rubinstein LV, Lung Study Group. Randomized trial of lobectomy versus limited resection for T1N0 non-small cell lung cancer. Ann Thorac Surg. 1995;60:615–23.PubMedCrossRef
22.
go back to reference Patz EF, Rossi S, Harpole DH, et al. Correlation of tumor size and survival in patients with stage IA non-small cell lung cancer. Chest. 2000;117:1568–71.PubMedCrossRef Patz EF, Rossi S, Harpole DH, et al. Correlation of tumor size and survival in patients with stage IA non-small cell lung cancer. Chest. 2000;117:1568–71.PubMedCrossRef
23.
go back to reference Pasic A, Postmus PE, Sutedja TG. What is early lung cancer? A review of the literature. Lung Cancer. 2004;45:267–77.PubMedCrossRef Pasic A, Postmus PE, Sutedja TG. What is early lung cancer? A review of the literature. Lung Cancer. 2004;45:267–77.PubMedCrossRef
24.
25.
go back to reference Suzuki K, Nagai K, Yoshida J, et al. Predictors of lymph node and intrapulmonary metastasis in clinical stage IA non-small cell lung carcinoma. Ann Thorac Surg. 2001;72:352–6.PubMedCrossRef Suzuki K, Nagai K, Yoshida J, et al. Predictors of lymph node and intrapulmonary metastasis in clinical stage IA non-small cell lung carcinoma. Ann Thorac Surg. 2001;72:352–6.PubMedCrossRef
26.
go back to reference Fukui T, Mori S, Yokoi K, et al. T significance of the number of positive lymph nodes in resected non-small cell lung cancer. J Thorac Oncol. 2006;1:120–5.PubMedCrossRef Fukui T, Mori S, Yokoi K, et al. T significance of the number of positive lymph nodes in resected non-small cell lung cancer. J Thorac Oncol. 2006;1:120–5.PubMedCrossRef
27.
go back to reference Hung JJ, Wang CY, Huang MH, et al. Prognostic factors in resected stage I non-small cell lung cancer with a diameter of 3 cm or less: visceral pleural invasion did not influence overall and disease-free survival. J Thorac Cardiovasc Surg. 2007;134:638–43.PubMedCrossRef Hung JJ, Wang CY, Huang MH, et al. Prognostic factors in resected stage I non-small cell lung cancer with a diameter of 3 cm or less: visceral pleural invasion did not influence overall and disease-free survival. J Thorac Cardiovasc Surg. 2007;134:638–43.PubMedCrossRef
28.
go back to reference Miller DL, Rowland CR, Deschamps C, et al. Surgical treatment of non-small cell lung cancer 1 cm or less in diameter. Ann Thorac Surg. 2002;73:1545–51.PubMedCrossRef Miller DL, Rowland CR, Deschamps C, et al. Surgical treatment of non-small cell lung cancer 1 cm or less in diameter. Ann Thorac Surg. 2002;73:1545–51.PubMedCrossRef
29.
go back to reference Takizawa T, Terashima M, Koike T, et al. Lymph node metastasis in small peripheral adenocarcinoma of the lung [J]. J Thorac Cardiovasc Surg. 1998;116:276–80.PubMedCrossRef Takizawa T, Terashima M, Koike T, et al. Lymph node metastasis in small peripheral adenocarcinoma of the lung [J]. J Thorac Cardiovasc Surg. 1998;116:276–80.PubMedCrossRef
30.
go back to reference Kim BT, Kim Y, Lee KS, et al. Localized form of bronchioloalveolar carcinoma. AJR. 1998;170:935–9.PubMed Kim BT, Kim Y, Lee KS, et al. Localized form of bronchioloalveolar carcinoma. AJR. 1998;170:935–9.PubMed
31.
go back to reference Nakajima R, Yokose T, Kakinuma R, et al. Localized pure ground-glass opacity on high-resolution CT: histologic characteristics. J Comput Assist Tomogr. 2002;26:323–9.PubMedCrossRef Nakajima R, Yokose T, Kakinuma R, et al. Localized pure ground-glass opacity on high-resolution CT: histologic characteristics. J Comput Assist Tomogr. 2002;26:323–9.PubMedCrossRef
32.
go back to reference Kodama K, Higashiyama M, Yokouchi H, et al. Natural history of pure ground-glass opacity after long-term follow-up of more than 2 years. Ann Thorac Surg. 2002;73:386–93.PubMedCrossRef Kodama K, Higashiyama M, Yokouchi H, et al. Natural history of pure ground-glass opacity after long-term follow-up of more than 2 years. Ann Thorac Surg. 2002;73:386–93.PubMedCrossRef
33.
go back to reference Aoki T, Nakata H, Watanabe H, et al. Evolution of peripheral lung adenocarcinomas: CT findings correlated with histology and tumor doubling time. AJR. 2000;174:763–8.PubMed Aoki T, Nakata H, Watanabe H, et al. Evolution of peripheral lung adenocarcinomas: CT findings correlated with histology and tumor doubling time. AJR. 2000;174:763–8.PubMed
34.
go back to reference Yamato Y, Tsuchida M, Watanabe T, et al. Early resection for brochioloalveolar adenocarcinoma of the lung. Ann Thorac Surg. 2001;71:971–4.PubMedCrossRef Yamato Y, Tsuchida M, Watanabe T, et al. Early resection for brochioloalveolar adenocarcinoma of the lung. Ann Thorac Surg. 2001;71:971–4.PubMedCrossRef
35.
go back to reference Yoshida J, Nagai K, Yokose T, et al. Limited resection trial of pulmonary ground-glass opacity nodules: fifty-case experience. J Thorac Cardiovasc Surg. 2005;129:991–6.PubMedCrossRef Yoshida J, Nagai K, Yokose T, et al. Limited resection trial of pulmonary ground-glass opacity nodules: fifty-case experience. J Thorac Cardiovasc Surg. 2005;129:991–6.PubMedCrossRef
36.
go back to reference Yamato Y, Tsuchida M, Watanabe T, et al. Early results of a prospective study of limited resection for bronchioloalveolar adenocarcinoma of the lung. Ann Thorac Surg. 2001;71:971–4.PubMedCrossRef Yamato Y, Tsuchida M, Watanabe T, et al. Early results of a prospective study of limited resection for bronchioloalveolar adenocarcinoma of the lung. Ann Thorac Surg. 2001;71:971–4.PubMedCrossRef
37.
go back to reference Nakata M, Sawada S, Yamashita M, et al. Objective radiologic analysis of ground-glass opacity aimed at curative limited resection for small peripheral non-small cell lung cancer. J Thorac Cardiovasc Surg. 2005;129:1226–31.PubMedCrossRef Nakata M, Sawada S, Yamashita M, et al. Objective radiologic analysis of ground-glass opacity aimed at curative limited resection for small peripheral non-small cell lung cancer. J Thorac Cardiovasc Surg. 2005;129:1226–31.PubMedCrossRef
38.
go back to reference Lung Cancer Study Group. Randomized trial of lobectomy versus limited resection for T1N0 non-small cell lung cancer. Ann Thorac Surg. 1995;60:615–23.CrossRef Lung Cancer Study Group. Randomized trial of lobectomy versus limited resection for T1N0 non-small cell lung cancer. Ann Thorac Surg. 1995;60:615–23.CrossRef
39.
go back to reference Kondo D, Yamada K, Kitayama Y, et al. Peripheral lung adenocarcinomas: 10 mm or less in diameter. Ann Thorac Surg. 2003;76:350–5.PubMedCrossRef Kondo D, Yamada K, Kitayama Y, et al. Peripheral lung adenocarcinomas: 10 mm or less in diameter. Ann Thorac Surg. 2003;76:350–5.PubMedCrossRef
40.
go back to reference Ikeda N, Maeda J, Yashima K, et al. A clinicopathological study of resected adenocacinoma 2 cm of less in diameter. Ann Thorac Surg. 2004;78:1011–6.PubMedCrossRef Ikeda N, Maeda J, Yashima K, et al. A clinicopathological study of resected adenocacinoma 2 cm of less in diameter. Ann Thorac Surg. 2004;78:1011–6.PubMedCrossRef
41.
go back to reference Inoue M, Minami M, Shiono H, et al. Clinicopathologic study of resected, peripheral, small-sized, non-small cell lung cancer tumors of 2 cm or less in diameter: pleural invasion and increase of serum carcinoembryonic antigen level as predictors of nodal involvement. J Thorac Cardiovasc Surg. 2006;131:988–93.PubMedCrossRef Inoue M, Minami M, Shiono H, et al. Clinicopathologic study of resected, peripheral, small-sized, non-small cell lung cancer tumors of 2 cm or less in diameter: pleural invasion and increase of serum carcinoembryonic antigen level as predictors of nodal involvement. J Thorac Cardiovasc Surg. 2006;131:988–93.PubMedCrossRef
42.
go back to reference Fukui T, Katayama T, Ito S, et al. Clinicopathological features of small-sized non-small cell lung cancer with mediastinal lymph node metastasis. Lung Cancer. 2009;66:309–13.PubMedCrossRef Fukui T, Katayama T, Ito S, et al. Clinicopathological features of small-sized non-small cell lung cancer with mediastinal lymph node metastasis. Lung Cancer. 2009;66:309–13.PubMedCrossRef
Metadata
Title
A clinicopathological study of resected non-small cell lung cancers 2 cm or less in diameter: a prognostic assessment
Authors
Chun-Lei Shi
Xue-Yan Zhang
Bao-Hui Han
Wei-Zhong He
Jie Shen
Tian-Qing Chu
Publication date
01-12-2011
Publisher
Springer US
Published in
Medical Oncology / Issue 4/2011
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-010-9632-y

Other articles of this Issue 4/2011

Medical Oncology 4/2011 Go to the issue